Normalization of liver enzymes in an HIV-hepatitis C virus-co-infected patient after potent antiretroviral therapy.
Diaz
Beatriz
B
Martín-Carbonero
Luz
L
Pérez-Olmeda
Mayte
M
Soriano
Vincent
V
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000201:enzymology*; D000328:Adult; D000410:Alanine Transaminase / Q000097:blood*; D000480:Alkynes; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood*; D048588:Benzoxazines; D018791:CD4 Lymphocyte Count; D003521:Cyclopropanes; D004359:Drug Therapy, Combination; D005260:Female; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy / Q000201:enzymology*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D008099:Liver / Q000201:enzymology*; D010078:Oxazines / Q000627:therapeutic use; D012367:RNA, Viral / Q000097:blood; D015215:Zidovudine / Q000627:therapeutic use
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D012367:RNA, Viral; D019259:Lamivudine; D015215:Zidovudine; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; C098320:efavirenz